University of Campania Luigi Vanvitelli
unicampania.itTotal trials
171
Active
24
Phase 3
7
Total enrollment
59,075
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Insulin injections | — | — | — | — | — | 1 | |
| FOLFIRI | — | — | — | — | 2 | ||
| Bevacizumab | — | — | — | — | 2 | ||
| Erbitux | — | — | — | — | — | 1 | |
| FOLFOX | — | — | — | — | — | 1 | |
| Cetuximab | — | — | — | — | — | 3 | |
| FOLFOX regimen | — | — | — | — | — | 1 | |
| Irinotecan | — | — | — | — | — | 1 | |
| umPEALUT + Rutin + 5 hTp | — | — | — | — | — | 1 |
Next readouts
- 2026-08-15
- 2026-10-31
- 2026-12
- 2030-10
Top conditions
- Heart Failure8
- Atrial Fibrillation5
- Type 2 Diabetes Mellitus4
- Diabetes Mellitus4
- Obesity4
- Type 2 Diabetes4
- Diabetes Mellitus, Type 23
- Endometrial Neoplasms3
Frequently asked questions about University of Campania Luigi Vanvitelli
- How many clinical trials does University of Campania Luigi Vanvitelli have on ClinicalTrials.gov?
- University of Campania Luigi Vanvitelli is listed as the lead sponsor on 171 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Campania Luigi Vanvitelli's trials are in Phase 3?
- 7 of University of Campania Luigi Vanvitelli's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does University of Campania Luigi Vanvitelli focus on?
- University of Campania Luigi Vanvitelli's most-studied conditions on ClinicalTrials.gov are Heart Failure, Atrial Fibrillation, Type 2 Diabetes Mellitus, Diabetes Mellitus, Obesity.
- When are University of Campania Luigi Vanvitelli's next clinical trial readouts?
- University of Campania Luigi Vanvitelli has 4 upcoming primary-completion readouts tracked here; the soonest is “CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen”, expected around 2026-08-15.